Cost-Consequences of Adding Gliclazide Modified Release to Metformin in Patients with Uncontrolled Type 2 Diabetes in the United Arab Emirates. [PDF]
Farghaly M +3 more
europepmc +1 more source
Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes. [PDF]
Dániel E +7 more
europepmc +1 more source
DPP4-inhibition reduces pro-inflammatory cytokine production by alpha-beta and gamma-delta T cells in vitro and in the biliary atresia mouse model. [PDF]
Wilde AC +7 more
europepmc +1 more source
Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal barrier components. [PDF]
Simó R +3 more
europepmc +1 more source
Sitagliptin Mitigates Diabetic Cardiomyopathy Through Oxidative Stress Reduction and Suppression of VEGF and FLT-1 Expression in Rats. [PDF]
Alqahtani QH +6 more
europepmc +1 more source
Ultrasensitive, green molecularly-imprinted poly(o-phenylenediamine) sensor on pencil graphite for trace ertugliflozin quantification in plasma and tablets. [PDF]
Farrag M +3 more
europepmc +1 more source
High-fat diet feeding significantly attenuates anagliptin-induced regeneration of islets of Langerhans in streptozotocin-induced diabetic mice [PDF]
core +1 more source
Sitagliptin, a DPP-4 Inhibitor, Effectively Promotes the Healing of Diabetic Foot Ulcer: A Randomized Controlled Trial. [PDF]
Gao W +5 more
europepmc +1 more source
Sitagliptin ameliorates microbial dysbiosis and enhances gut barrier integrity in streptozotocin-induced type 2 diabetic rats. [PDF]
Chang Y +5 more
europepmc +1 more source

